Effects of Hydroethanolic Rhizome Extract of Anchomanes difformis (Blume) in Type 2 (Streptozocin-Nicotinamide-Induced) Diabetic Rats http://www.doi.org/10.26538/tjnpr/v8i1.44
Article Sidebar
Main Article Content
Abstract
Diabetes mellitus remains a huge public health concern. Anchomanes difformis Blume is an herbaceous plant with numerous folkloric uses. This study investigated the acute and sub-acute effects of hydroethanolic rhizome extracts of A. difformis (AD) on glucose level in normal and diabetic Sprague-Dawley rats. Type 2 diabetes was induced with streptozotocin (65 mg/kg) administration after nicotinamide (120 mg/kg) i.p. Diabetic rats were divided into five groups: diabetic control (distilled water 10 mL/kg, p.o.), A. difformis (125, 250 and 500 mg/kg, p.o.) and glibenclamide (2.5 mg/kg, p.o.). Group 6 was normal control (non-diabetic; distilled water 10 mL/kg, p.o.). Treatments were done for 21 days. Body weight and fasting blood glucose level of the animals were determined weekly. On day 21, blood samples were collected for serum biochemical and lipid profile assays. Vital organs were collected for assay of tissue antioxidant levels and histopathological assessment. AD produced significant (P<0.05-0.001) dose-dependent reduction in blood glucose level with peak effects at 500 mg/kg dose on day 21. 500 mg/kg AD elicited significant increase in the levels of SOD and CAT in the liver, kidney and pancreas. The level of ALP was significantly reduced in diabetic rats by AD (250-500 mg/kg). 250-500 mg/kg AD significantly reduced the levels of creatinine and urea, with significant increase in total protein levels. 500 mg/kg AD significantly reduced (P<0.05) cholesterol level. No significant histopathological distortions were observed in vital organs. The effects of AD extract were comparable to that of glibenclamide. Findings in this study suggest that AD possesses significant antidiabetic effect.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
The International Diabetes Federation (IDF). IDF Diabetes Atlas 10th Edition 2021. Avenue Herrmann-Debroux 54B-1160 Brussels, Belgium.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the
International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019; 157. Doi: 10.1016/j.diabres.2019.107843
Emerging Risk Factors Collaboration; Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375:2215-2222. Doi: 10.1016/S0140-6736(10)60484-9
Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR; Vision Loss Expert Group. Causes of vision loss worldwide, 1990-2010: A systematic analysis. Lancet Glob Health. 2013; 1(6):e339-349. Doi: 10.1016/S2214-109X(13)70113-X
Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA. US renal data system 2015 annual data report: Epidemiology of kidney disease in the United States. Am J. Kidney Dis. 2016; 67(3 Suppl 1):Svii, S1-305. Doi: 10.1053/j.ajkd.2015.12.014
Ozieh MN, Bishu KG, Dismuke CE, Egede LE. Trends in health care expenditure in U.S. adults with Diabetes: 2002-2011. Diabetes Care. 2015; 38:1844-1851. Doi: 10.2337/dc15-0369
Centers for Disease Control and Prevention. National diabetes statistics report: Estimates of diabetes and its burden in the United States. U.S. Department of Health and Human Services, 2014.
Dinh NTT, de Graaff B, Campbell JA, Jose MD, John B, Saunder T, Kitsos A, Wiggins N, Palmer AJ. Costs of major complications in people with and without diabetes in Tasmania, Australia. Aust Health Rev. 2022; 46(6):667-678. Doi: 10.1071/AH22180
Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, Davies J, Vollmer S. Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care. 2018; 41:963-970. doi: 10.2337/dc17-1962
World Health Organization. Global Report on Diabetes. WHO, 2016.
Odusan O, Ale AO, Moji NC. Differences in demographic and clinical variables among some African ethnic groups with T2DM. Afr J. Med Med Sci. 2020; 49:393-398.
Vinik AI, Pittenger G, Fishwick DT. Advances in diabetes for the millennium: Toward a cure for diabetes CME. MedGenMed. 2004; 6(3 Suppl):12.
Aderonke SO, Ezinwanne AJ. Evaluation of the antidiabetic activity of ethanol extract of Anchomanes difformis (Araceae) leaves in albino rats. Int Res J. Pharm 2015; 6:90-93. Doi: 10.7897/2230-8407.06221
Mishra Shanti Bhushan, Rao Ch. V, Sanjeev Ojha, Madhavan Vijayakumar VA. An analytical review of plants for antidiabetic activity with their phytoconstituent & mechanism of action. Int J. Pharm Sci Res. 2010; 3: 29-46. Doi: http://dx.doi.org/10.13040/IJPSR.0975-8232.1(1).29-46
Aliyu AB, Ibrahim MA, Musa AM, Musa AO, Kiplimo JJ, Oyewale AO. Free radical scavenging and total antioxidant capacity of root extracts of Anchomanes difformis Engl. (Araceae). Acta Pol Pharm. 2013; 70:115-121.
Ahmed HA. Anchomanes difformis: A multipurpose phytomedicine. IOSR J. Pharm Biol Sci. 2018;13:62-65. Doi: 10.9790/3008-1302036265
Aliyu AB, Musa AM, Abdullahi MS, Oyewale AO, Gwarzo US. Activity of plant extracts used in Northern Nigerian traditional medicine against methicillin-resistant Staphylococcus aureus (MRSA). Nig J. Pharm Sci. 2008; 7(1): 119-125.
Adebayo AH, John-Africa LB, Agbafor AG, Omotosho OE, Mosaku TO. Anti-nociceptive and anti-inflammatory activities of extract of Anchomanes difformis in rats. Pak J. Pharm Sci. 2014; 27(2):265-270.
Faleye FJ, Akinwunmi OA, Ojo OC. Investigation of the methanol extract of Anchomanes difformis tuber extract for in vitro antioxidant, α-amylase and α-glucosidase inhibitory activities. FUW Trends Sci Tech J. 2018; 3(2A):342-346.
Oyetayo VO. Comparative studies of the phytochemical and antimicrobial properties of the leaf, stem and tuber of Anchomanes difformis. J. Pharmacol Toxicol. 2007; 2:407-410. Doi: 10.3923/jpt.2007.407.410
Okpo S, Ching F, Ayinde B, Alonge P, Udi O. Antiulcer activity of the ethyl acetate fraction of Anchomanes difformis. Planta Med 2009;75. Doi: 10.1055/s-0029-1234762
Okpo SO, Ching FP, Ayinde BA, Udi OO, Alonge PO, Eze GO. Gastroprotective effects of the ethyl acetate fraction of Anchomanes difformis (Engl). Int J. Health Res 2011; 4(4):155-161.
Oghale OU, Idu M. Phytochemistry, anti-asthmatic and antioxidant activities of Anchomanes difformis (Blume) Engl. leaf extract. Asian Pac J. Trop Biomed. 2016; 6(3):225-231. https://doi.org/10.1016/j.apjtb.2015.12.007
Adeyemi O, Makinwa TT, Uadia RN. Ethanol extracts of roots of Anchomanes difformis Engl. roots as an antihyperglycemic agent in diabetic rats. Chem J. 2015; 1(3):68-73.
Agyare C, Boakye YD. Antimicrobial and anti-inflammatory properties of Anchomanes difformis (Bl.) Engl. and Colocasia esculenta (L.) Schott. Biochem Pharmacol. 2015; 5:201. Doi: 10.4172/2167-0501.1000201
Nkoh NJ, Ngemenya MN, Samje M, Yong JN. Anti-onchocercal and antibacterial activities of crude extracts and secondary metabolites from the rhizome of Anchomanes difformis (Araceae). J. Cameroon Acad Sci. 2015; 12(1);19-30.
Akinkurolere RO. Assessment of the insecticidal properties of Anchomanes difformis (P. Beauv.) powder on five beetles of stored produce. J. Entomol. 2007; 4(1):51-55. Doi: 10.3923/je.2007.51.55
Ordoñez AAL, Gomez JD, Vattuone MA, Isla MI. Antioxidant activities of Sechium edule (Jacq.) Swartz extracts. Food Chem. 2006; 97:452-458. https://doi.org/10.1016/j.foodchem.2005.05.024
Aziz M, Nime M, Rahman M, Khatun Z, Habib M, Siddika A, Khatun M, Karim M. Studies on antioxidant and antineoplastic potentials of Oldenlandia corymbosa Linn. leaves. J. Fundam Appl Pharmaceut Sci. 2023; 3(2):83-98. Doi: https://doi.org/10.18196/jfaps.v3i2.17737
Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J. Agric Food Chem. 2003; 51:609-614. Doi: 10.1021/jf020782a
Orhan N, Aslan M, Orhan DD, Ergun F, Yeşilada E. In-vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vinifera) in diabetic rats. J. Ethnopharmacol. 2006; 108(2): 280-286. Doi: 10.1016/j.jep.2006.05.010
Aboonabi A, Rahmat A, Othman F. Antioxidant effect of pomegranate against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Toxicol Rep. 2014; 1:915-922. doi: 10.1016/j.toxrep.2014.10.022
Aslan M, Orhan N, Orhan DD, Ergun F. Hypoglycemic activity and antioxidant potential of some medicinal plants traditionally used in Turkey for diabetes. J. Ethnopharmacol. 2010; 128(2):384-389. doi: 10.1016/j.jep.2010.01.040
Akindele A, Oladimeji-Salami J, Oyetola R, Osiagwu D. Sub-chronic toxicity of the hydroethanolic leaf extract of Telfairia occidentalis Hook. f. (Cucurbitaceae) in male rats. Medicines (Basel). 2018; 5(1):4. doi: 10.3390/medicines5010004
Ishola IO, Akindele AJ, Adeyemi OO. Sub-chronic toxicity study of the methanol root extract of Cnestis ferruginea. Pharm Biol. 2012; 50:994-1006. Doi: 10.3109/13880209.2012.655376
Aliyu AB, Musa AM, Oshanimi JA, Ibrahim HA, Oyewale AO. Phytochemical analyses and mineral elements composition of some medicinal plants of Northern Nigeria. Nig J. Pharm Sci. 2008; 7(1):119-125.
Alabi TD, Brooks NL, Oguntibeju OO. Antioxidant capacity, phytochemical analysis and identification of active compounds in Anchomanes difformis. Nat Prod J. 2020; 10(4):446-458. Doi: 10.2174/2210315509666190422155347
Roslan J, Giribabu N, Karim K, Salleh N. Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats. Biomed Pharmacother. 2017; 86:570-582. Doi: 10.1016/j.biopha.2016.12.044
Najafian M, Jahromi MZ, Nowroznejhad MJ, Khajeaian P, Kargar MM, Sadeghi M, Arasteh A. Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats. Mol Biol Rep. 2012; 39:5299-5306. Doi: 10.1007/s11033-011-1328-7
Hidalgo M, Sánchez-Moreno C, de Pascual-Teresa S. Flavonoid-flavonoid interaction and its effect on their antioxidant activity. Food Chem. 2010; 121:691-696. https://doi.org/10.1016/j.foodchem.2009.12.097
Pietta PG. Flavonoids as antioxidants. J. Nat Prod. 2000; 63:1035-1042. Doi: 10.1021/np9904509
Egharevba E, Chukwuemeke-Nwani P, Eboh U, Okoye E, Bolanle IO, Oseghale IO, Imieje VO, Erharuyi O, Falodun A. Evaluation of the antioxidant and hypoglycaemic potentials of the leaf extracts of Stachytarphyta jamaicensis (Verbenaceae). Trop J. Nat Prod Res. 2019; 3(5):170-174. doi.org/10.26538/tjnpr/v3i5.4
Burda S, Oleszek W. Antioxidant and antiradical activities of flavonoids. J. Agric Food Chem 2001; 49(6): 2774-2779. Doi: 10.1021/jf001413m
Ovuakporie-Uvo O, Idu M, Eze G, Ozolua R. Toxicological studies of Anchomanes difformis Blume (Araceae) using rats and mice. Int J. Basic Clin Pharmacol. 2015; 4(6):1228-1234. Doi: https://doi.org/10.18203/2319-2003.ijbcp20151364
OvuakporieUvo O, Idu M. Effect of the aqueous leaf extract of Anchomanes difformis on the glucose level and organ/ body weight ratio of Wistar rats. J. Med Herbs Ethnomedicine. 2015; 1:64. Doi: 10.5455/jmhe.2015.07.012
Alabi TD, Chegou NN, Brooks NL, Oguntibeju OO. Effects of Anchomanes difformis on inflammation, apoptosis, and organ toxicity in STZ-induced diabetic cardiomyopathy. Biomedicines 2020; 8(2):29. Doi: 10.3390/biomedicines8020029
Raza M, Al-Shabanah OA, El-Hadiyah TM, Al-Majed AA. Effect of prolonged vigabatrin treatment on hematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice. Sci Pharm. 2002; 70:135-145. https://doi.org/10.3797/scipharm.aut-02-16
Tan PV, Mezui C, Enow-Orock G, Njikam N, Dimo T, Bitolog P. Teratogenic effects, acute and sub chronic toxicity of the leaf aqueous extract of Ocimum suave Wild (Lamiaceae) in rats. J. Ethnopharmacol 2008; 115:232-237. doi: 10.1016/j.jep.2007.09.022
Zafar M, Naeem-ul-Hassan Naqvi S. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: A comparative study. Int J. Morphol 2010; 28:135-142. http://dx.doi.org/10.4067/S0717-95022010000100019
Ataman E J, Idu M. Renal effects of Anchomanes difformis crude extract in wistar rats. Avicenna J Phytomedicine 2015; 5:17-25.